ED raids premises of Srisan Pharmaceuticals and Tamil Nadu FDA in serious case of death of children due to Coldriff cough syrup. The action was taken under the Prevention of Money Laundering Act as poisonous syrup containing diethylene glycol took the lives of more than 20 children, raising serious questions over regulatory failure and criminal negligence.
Read this also: Nitin Gadkari Puducherry Visit | Puducherry’s development will gain momentum! Gadkari will lay the foundation stone of highway projects worth Rs 2000 crore including elevated corridor
The Enforcement Directorate (ED) on Monday raided the premises of Shreesan Pharmaceuticals, the manufacturer of cough syrup Coldrif, believed to be responsible for the deaths of children in Madhya Pradesh and Rajasthan, and top officials of the Tamil Nadu FDA. Official sources gave this information.
Sources said the Enforcement Directorate took this action under the Prevention of Money Laundering Act (PMLA) in at least seven premises in Chennai. At least 20 children, most of whom were under five years of age, died after being given Coldrif in Madhya Pradesh and Rajasthan.
Read this also: Miracle of Cricket Commentary: ₹ 35,000 to ₹ 10 lakh per day, Aakash Chopra told the game of earning
The Central Drugs Standard Control Organization (CDSCO) has said that Kancheepuram-based Sreesan Pharma, which got a license from the Tamil Nadu Food and Drug Administration (TNFDA) in 2011, continued to operate for more than a decade despite its poor infrastructure and multiple violations of National Drug Safety Rules.
Cough syrup was found to be adulterated with a highly toxic substance called diethylene glycol (DEG) at ‘dangerous’ levels. Srisan Pharmaceuticals owner G Ranganathan was arrested by Madhya Pradesh Police on October 9.